HomeMidazolamMidazolam + Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F

Does Midazolam Interact with Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F?

Midazolam and Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F have a unknown drug interaction according to U.S. FDA drug labeling data. 7.6 Drugs without Clinically Significant Interactions with BIKTARVY Based on drug interaction studies conducted with BIKTARVY or the components of BIKTARVY, no clinically significant drug interactions have been observed when BIKTARVY is combined with the following drugs: ethinyl estradiol, ledipasvir/sofosbuvir, midazolam, norgestimate, sertraline, sofosbuvir, sofosbuvir/velpatasvir, and sofosbuvir/velpatasvir/voxilaprevir. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Midazolam Class
Benzodiazepine
Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Midazolam and your doctor is considering prescribing Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Midazolam(Nayzilam)+💊 Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F(Biktarvy)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Benzodiazepine
Drug B class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Source
FDA drug label - bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate

What this means in plain English

7.6 Drugs without Clinically Significant Interactions with BIKTARVY Based on drug interaction studies conducted with BIKTARVY or the components of BIKTARVY, no clinically significant drug interactions have been observed when BIKTARVY is combined with the following drugs: ethinyl estradiol, ledipasvir/sofosbuvir, midazolam, norgestimate, sertraline, sofosbuvir, sofosbuvir/velpatasvir, and sofosbuvir/velpatasvir/voxilaprevir.

About Midazolam and Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F

Midazolam is a Benzodiazepine, while Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F is a Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Nayzilam and Biktarvy. Midazolam is given by intravenous (IV) infusion, whereas Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F is taken by mouth. Both Midazolam and Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F carry an FDA boxed warning — the agency's most serious safety designation.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Midazolam and Bictegravir Sodium Emtricitabine And Tenofovir Alafenamide F against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.